Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......
The COVID-19 pandemic took a deadlier and more devastating turn in 2021 soon after a glimmer of hope was provided by the launch of vaccines at the beginning of the year, etching nightmarish......
'Antibodies remain in the blood for at least seven to nine months.' IMAGE: Vaccination on the road at Salamandra village, Margo Munda, in Deoghar, Jharkhand, December 23, 2021. Photograph: ANI......
Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said.......
The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Biotech's Covaxin for children above 12 years with certain conditions, official......
Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......
The Indian equity markets will soon account for over a fifth of a key emerging market (EM) benchmark tracked by funds with assets exceeding $500 billion. Photograph: Thomas White/Reuters This......
Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by......
While companies remain cautiously optimistic about demand panning out this year, a dry August has already played spoilsport for demand, especially in rural areas. Higher inflation has again become......
Irregular rainfall and a pick-up in commodity costs are expected to weigh on the demand and margins of fast-moving consumer goods (FMCG) companies. Photograph: Mansi Thapliya/Reuters Most......